Viral Vector and Plasmid DNA: Technologies and Global Markets

Report Code: BIO192B

Publish Date: Apr 2024

Publisher: BCC Publishing

Category: Cell Biology

Download Report Overview

Single User License: $5500

Member Price: FREE

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global market for viral vector and plasmid DNA technologies is expected to grow from $2.9 billion in 2023 to $7.1 billion by the end of 2028, at a compound annual growth rate (CAGR) of 19.7% from 2023 through 2028.

Report Includes

  • 93 data tables and 47 additional tables
  • An overview of the global market for viral vector and plasmid DNA
  • Analyses of global market trends, with data from 2020-2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
  • Evaluation of the current market size and revenue growth prospects for viral vector and plasmid DNA, along with a market share analysis by product type, application and geographic region
  • A look at the innovations, technological advances, and product launches from leading companies
  • Analysis of the industry’s regulatory framework and policies, and its product pipeline
  • Discussion of ESG challenges and ESG practices
  • Analysis of the key companies’ market shares, proprietary technologies, strategic alliances and other market strategies, and patents
  • Profiles of the leading players in the industry

Report Scope

The report provides a comprehensive summary of the viral vector and plasmid DNA technologies market focusing cell and gene therapies, along with detailed competitive landscape and profiles of key market players that include revenue, product portfolios and recent activities. The report analyzes trends and dynamics, including drivers, limitations, challenges, and opportunities. This research study discusses historical, current, and potential market size. The report will enable market players and new entrants to make informed decisions about the production and licensing of goods and services. Organizations, distributors, and exporters should find the information about market development and trends useful. The study segments the market on the basis of product type, applications, and end use. Geographical market analysis is provided for all the major segments. The report offers country-level analysis of markets to provide a better understanding of the major segments.

The market is divided into segments and by application/industry as follows:

By product type:

  • Viral vector.
  • Plasmid DNA.

By application:

  • Cancer.
  • Genetic disorders.
  • Infectious diseases.
  • Cardiovascular diseases.
  • Other diseases.

By end-user:

  • Research institutes.
  • Pharmaceutical and biopharmaceutical companies.

Each area is covered in detail, identifying current products in the market in the base year (2022), measuring the current market size and identifying current and potential market drivers, forecasting for 2028, assessing current and potential competitors, and identifying current competitor market shares for 2022.

Report Synopsis

Report Metrics Details
Base year considered 2022
Forecast period considered 2023-2028
Base year market size $2.4 billion
Market size forecast $7.1 billion
Growth rate CAGR of 19.7% from 2023 to 2028
Units considered $ Millions
Segments covered By Product Type, Application, End User, and Region
Regions covered North America, Europe, Asia-Pacific, Latin America, and the Rest of the World (RoW)
Key Market Drivers
  • Rising incident cases of cancer.
  • Surge in viral vectors and plasmid DNA production.
  • Accelerated FDA approval of cell and gene therapies
Companies studied
AGILENT TECHNOLOGIES INC.BLUEBIRD BIO INC.
CATALENT INC.DANAHER CORP.
FUJIFILM HOLDINGS CORP.GENSCRIPT
GILEAD SCIENCES INC.LONZA
NOVARTIS AGOXFORD BIOMEDICA PLC
PLASMIDFACTORY GMBHREGENXBIO INC.
THERMO FISHER SCIENTIFIC INC.VGXI INC.
Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW

Frequently Asked Questions (FAQs)

The global viral vector and plasmid DNA market is projected to grow from $2.4 billion in 2022 to $7.1 billion in 2028 at a compound annual growth rate (CAGR) of 19.7% during the forecast period.
The viral vector and plasmid DNA technologies market is driven by the increasing adoption of viral vector associated cell and gene therapies for cancer and rare genetic disorders. Contract development manufacturers and biopharmaceutical companies increasing the scale of production to meet the surge for viral vectors and plasmid DNA due to accelerated FDA approvals of cell and gene therapies are the key factors driving the market growth.
The viral vector and plasmid DNA technologies market is segmented based on the product type, by application and by geographic region.
The viral vector segment will dominate the market by the end of 2028.

Analyst Credentials

Gundreddy Gopinadh– Associate Consultant-Life Sciences Research
Gopinadh is an experienced professional with nearly nine years in the market research industry and experience in research and analysis, specializing in medical devices, pharmaceuticals, biotechnology, and in-vitro diagnostics verticals. He is an expert in handling custom projects by gathering data points, analyzing market trends, and ultimately providing clients with accurate market size numbers, actionable insights, and recommendations based on their unique business needs. Academically, Gopinadh holds a master’s degree in biotechnology from VIT University.

Let us assist you! Our analysts are ready to tailor this report to your specific need. REACH OUT TO US TODAY

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Viral Vector and Plasmid DNA: Technologies and Global Markets130Free
Chapter- 1: Executive Summary5Free
Chapter- 2: Market Overview 1Free
Chapter- 3: Market Dynamics 7Free
Chapter- 4: Emerging Technologies and Developments 11Free
Chapter- 5: Global Market for Viral Vector and Plasmid DNA Technologies48Free
Chapter- 6: Competitive Intelligence3Free
Chapter- 7: Sustainability in the Market for Viral Vector and Plasmid DNA Technologies: An ESG Perspective5Free
Chapter- 8: Appendix50Free
Published - Oct-2019| Analyst - Anuj Pathak| Code - BIO192A

Report Highlights

The global viral vector and plasmid DNA technologies market should grow from $500 million in 2019 to over $1.1 billion by 2024 with a compound annual growth rate (CAGR) of 18.0% during the period, 2019-2024.

Report Includes

  • 44 data tables and 14 additional tables
  • An in-depth assessment of the global viral vector and plasmid DNA technologies market within the life sciences sectors
  • Analyses of global market trends, with data from 2018, estimates for 2019, and projections of compound annual growth rates (CAGRs) through 2024
  • The latest information on key technical advances in different viral vector and plasmid DNA technologies, and the extent of adoption by commercial customers and regulatory authorities
  • A proprietary analysis of the market including an easy-to-understand graphical representation of facts, innovations in pharmaceutical and biotechnology companies, and R&D activities in viral vector-based treatments and Plasmid DNA vaccines
  • Key strategies adopted by major players in the market and the impact of new technological developments in developed and emerging markets
  • Assessment of the suppliers’ landscape on the basis of companies best positioned to meet this ever evolving demand
  • Comprehensive company profiles of market leading players, including Aldevron LLC, Merck KGaA, Lonza Group Ltd., GenScript Biotech Corp., Pfizer Inc., and Thermo Fisher Scientific, Inc.

Related Reports

Global Market for Cell and Gene Therapy

Published - Apr 2024 | Publisher - BCC Publishing | Code - BIO225B

The global market for cell and gene therapy is expected to grow from $7.2 billion in 2023 and projected to reach $23.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 26.4% during the forecast period of 2023 to 2028. 

mRNA: Therapeutics and Global Markets

Published - Jan 2024 | Publisher - BCC Publishing | Code - BIO212B

The global market for mRNA therapeutics is expected to decline from $33 billion in 2023 to $21 billion by the end of 2028, at a compound annual growth rate (CAGR) of -8.6% during the forecast period of 2023-2028.

Cell and Gene Therapy Manufacturing Services Market

Published - Aug 2023 | Publisher - BCC Publishing | Code - BIO245A

The global cell and gene therapy manufacturing services market reached $4.9 billion in 2022, should reach $5.7 billion by 2023 and $11.8 billion by 2028 with a compound annual growth rate (CAGR) of 15.7% during the forecast period of 2023-2028.

Recent Reports

Gene Synthesis: Technologies and Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - BIO251A

The global market for Gene Synthesis is estimated to increase from $2.0 billion in 2023 to reach $4.1 billion by 2028, at a compound annual growth rate (CAGR) of 15.8% from 2023 through 2028.

Flow Cytometry: Products, Technologies and Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - BIO085F

The global market for flow cytometry products is expected to grow from $5.2 billion in 2023 to $8.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.2% from 2024 to 2029.

PEGylated Proteins Market

Published - May 2024 | Publisher - BCC Publishing | Code - BIO253A

The global market for PEGylated proteins is expected to grow from $10.2 billion in 2023 and projected to reach $15.9 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.4% during the forecast period of 2023 to 2028.

Companion Diagnostics: Technologies and Markets

Published - May 2024 | Publisher - BCC Publishing | Code - BIO077F

The global market for companion diagnostics is estimated to increase from $7.6 billion in 2023 to reach $15.4 billion by 2028, at a compound annual growth rate (CAGR) of 15.2% from 2023 through 2028.

Exosome Diagnostics, Therapeutics and Research Tools: Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - BIO149E

The global market for exosome diagnostics, therapeutics and research tools is estimated to increase from $227.5 million in 2023 to reach $1.3 billion by 2028, at a compound annual growth rate (CAGR) of 42.2% from 2023 through 2028.

Top Trending Reports

Global Market for Cell and Gene Therapy

Published - Apr 2024 | Publisher - BCC Publishing | Code - BIO225B

The global market for cell and gene therapy is expected to grow from $7.2 billion in 2023 and projected to reach $23.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 26.4% during the forecast period of 2023 to 2028. 

Peptide Synthesis: Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - BIO252A

The global market for peptide synthesis is expected to grow from $90.1 billion in 2023 and projected to reach $157.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.8% during the forecast period of 2023 to 2028.

3D Cell Cultures: Technologies and Global Markets

Published - Mar 2024 | Publisher - BCC Publishing | Code - BIO140D

The global market for 3D cell culture is estimated to increase from $4.6 billion in 2023 to reach $14.8 billion by 2028, at a compound annual growth rate (CAGR) of 26.5% from 2023 through 2028.

Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - HLC078F

The global market for medical magnetic resonance imaging (MRI) is expected to grow from $7.2 billion in 2023 and projected to reach $9.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.4% during the forecast period of 2023 to 2028.

Oligonucleotides: Global Markets

Published - Apr 2024 | Publisher - BCC Publishing | Code - BIO220B

The global market for oligonucleotides is expected to grow from $7.0 billion in 2023 and projected to reach $11.7 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2023 to 2028.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Viral Vector and Plasmid DNA: Technologies and Global Markets
Sample Report